Cognitive Impairment Associated with Cancer: A Brief Review

CONCLUSION Cognitive impairment can affect daily functioning, quality of life, and capacity to work in patients with cancer and those in remission. Consequently, cognitive assessment is now an important and necessary part of a comprehensive oncological care plan. Cancer-related cognitive impairment might be due to the direct effects of the cancer itself, nonspecific factors, or comorbid conditions that are independent of the disease and/or due to the adverse effects of the treatment or combination of treatments given for the disease. The prevalence and extent of cognitive impairment associated with cancer is recognized but not well understood due, in part, to marked differences in the research methods and definitions used for evaluating cognitive functioning in these patients. Most studies have identified attention, memory, and information processing as the most frequent cognitive domains impacted by cancer and cancer-related treatments, but further research clearly is needed. Recent efforts have been made to develop common definitions to define cognitive impairment in cancer patients and to suggest guidelines for the most appropriate cognitive tests to be used. Cognitive function has increasingly been recognized as a requisite therapeutic target in many diseases, including cancer. The extent of cognitive impairment that is observed in patients with cancer and those in remission make cognitive functioning a particularly important target for clinical trials and clinical practi...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Cognition Current Issue Neuro oncology Neurology Review cancer chemotherapy cognitive impairment neuropsychological assessment treatment Source Type: research

Related Links:

SMAD4 is the only common SMAD in TGF-β signaling that usually impedes immune cell activation in the tumor microenvironment. However, we demonstrated here that selective deletion of Smad4 in NK cells actually led to dramatically reduced tumor cell rejection and augmented tumor cell metastases, reduced murine CMV clearance, as well as impeded NK cell homeostasis and maturation. This was associated with a downregulation of granzyme B (Gzmb), Kit, and Prdm1 in Smad4-deficient NK cells. We further unveiled the mechanism by which SMAD4 promotes Gzmb expression. Gzmb was identified as a direct target of a transcriptional com...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
The stroma of solid tumors can exclude or limit immune infiltration, or lead to the recruitment of tumor-promoting rather than tumor-attacking immune cells. This finding was reported by Jayaprakash et al. in this issue of the JCI, and it was particularly prominent in the hypoxic zones of tumors in the transgenic adenocarcinoma of the mouse prostate (TRAMP) cancer models. A current clinical goal of immune checkpoint blockade (ICB) is to extend its utility to more patients by converting immunologically “cold” tumors that do not provoke a strong immunological response to “hot” tumors that are invaded b...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
Despite the success of immune checkpoint blockade against melanoma, many “cold” tumors like prostate cancer remain unresponsive. We found that hypoxic zones were prevalent across preclinical prostate cancer and resisted T cell infiltration even in the context of CTLA-4 and PD-1 blockade. We demonstrated that the hypoxia-activated prodrug TH-302 reduces or eliminates hypoxia in these tumors. Combination therapy with this hypoxia-prodrug and checkpoint blockade cooperated to cure more than 80% of tumors in the transgenic adenocarcinoma of the mouse prostate–derived (TRAMP-derived) TRAMP-C2 model. Immunofluo...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
One in four Americans goes to a therapist, and CBT is the most popular and safest treatment for depression. But 43 percent experience anxiety, break ups or other side effects, a German study reveals.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
The paper, titled 'Debt or Death?', used data on 9.5 million nationally-representative patients between 1998 and 2014, who spend an average of $92,098 a year trying to stay alive.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Adult scoliosis is different from the type children like Princess Eugenie develop - as Roger Neuberg, 77, from Leicester,experienced first-hand. This is his story.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Source: Peerview CME/CE Video Podcast - Internal Medicine International - Category: Internal Medicine Authors: Tags: Science, Medicine Source Type: video
Conclusion: GSTP1 and CYPs expressions are increased in intracranial tumors. These results should be confirmed with larger series and different enzyme subtypes.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research
Commonwealth Fund–supported researchers at the Long-Term Quality Alliance examined what we know and don’t know about working-age disabled Americans’ needs for long-term support. They share their findings in a new report.        
Source: The Commonwealth Fund: Publications - Category: International Medicine & Public Health Source Type: research
The start-up ’s optofluidic system could help get personalized cancer cell therapies to more people
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Amnesia | Antidoxidants | Anxiety | AstraZeneca | Avonex | Back Pain | Biotechnology | Brain | Brain Cancers | Brain Tumor | Breast Cancer | Breast Carcinoma | Cambridge University | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Chemotherapy | Child Development | Childhood Cancer | Children | Chronic Leukemia | Chronic Lymphocytic Leukemia | Chronic Pain | Clinical Trials | Colorectal Cancer | Computers | Concerta | Dementia | Depression | Disability | Docetaxel | Donepezil | Drugs & Pharmacology | Employment | Endocrine Therapy | Epidemiology | Epithelial Cancer | Gastroschisis Repair | Genetics | Geriatrics | Glioma | Headache | Health Management | Iron | Learning | Legislation | Leukemia | Lung Cancer | Lymphoma | Men | Menopause | Merck | Methotrexate | Methylphenidate | Middle East Health | Migraine | Mitochondrial Disease | Modafinil | MRI Scan | Myelodysplastic Syndrome | Myeloma | Namenda | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Netherlands Health | Neurology | Neuroscience | Neurosurgery | Nutrition | Occupational Health | Occupational Therapy | Ovarian Cancer | Ovaries | Oxford University | Pain | Pain Management | Pathology | Pediatrics | Pfizer | Pharmaceuticals | Primary CNS Lymphoma | Provigil | Psychiatry | Psychology | Radiation Therapy | Rebif | Rehabilitation | Ritalin | Science | Sleep Disorders | Sleep Medicine | Statistics | Study | Tamoxifen | Taxotere | Testicular Cancer | Toxicology | Training | UK Health | Universities & Medical Training | Women | Workshops